Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Zloza

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|January 10, 2014
Malignancies in HIV/AIDS: from epidemiology to therapeutic challengesPaul G Rubinstein, David M Aboulafia, Andrew Zloza
Current HIV Research|November 17, 2004
Immune modulation of HIV replication: relevance to HIV immuno- and neuro-pathogenesisElizabeth Z Managlia, Deborah Carroll, Andrew Zloza, et al.
Frontiers in Oncology|December 5, 2019
Editorial: Tumor Microenvironment and Resistance to Current TherapiesAhmed Lasfar, Murugabaskar Balan, Karine A Cohen-Solal, et al.
Oncoimmunology|May 31, 2019
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanomaPraveen K Bommareddy, Andrew Zloza, Samuel D Rabkin, et al.
Cancers|June 24, 2022
Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and ProgressionEileena F Giurini, Mary Beth Madonna, Andrew Zloza, et al.
Immunotherapy|July 7, 2016
IFN-λ cancer immunotherapy: new kid on the blockAhmed Lasfar, Helen Gogas, Andrew Zloza, et al.
Frontiers in Immunology|December 27, 2016
IFN-λ: A New Inducer of Local Immunity against Cancer and InfectionsAhmed Lasfar, Andrew Zloza, Andrew de la Torre, et al.
Vaccines|December 28, 2021
Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer ImmunotherapyKajal H Gupta, Christina Nowicki, Eileena F Giurini, et al.
Blood|June 7, 2003
CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIVAndrew Zloza, Yvonne B Sullivan, Elizabeth Connick, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 26, 2014
High-dose IL-2 induces rapid albumin uptake by endothelial cells through Src-dependent caveolae-mediated endocytosisAndrew Zloza, Dae Won Kim, Joseph Broucek, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|January 10, 2014
Malignancies in HIV/AIDS: from epidemiology to therapeutic challengesPaul G Rubinstein, David M Aboulafia, Andrew Zloza
Current HIV Research|November 17, 2004
Immune modulation of HIV replication: relevance to HIV immuno- and neuro-pathogenesisElizabeth Z Managlia, Deborah Carroll, Andrew Zloza, et al.
Frontiers in Oncology|December 5, 2019
Editorial: Tumor Microenvironment and Resistance to Current TherapiesAhmed Lasfar, Murugabaskar Balan, Karine A Cohen-Solal, et al.
Oncoimmunology|May 31, 2019
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanomaPraveen K Bommareddy, Andrew Zloza, Samuel D Rabkin, et al.
Cancers|June 24, 2022
Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and ProgressionEileena F Giurini, Mary Beth Madonna, Andrew Zloza, et al.
Immunotherapy|July 7, 2016
IFN-λ cancer immunotherapy: new kid on the blockAhmed Lasfar, Helen Gogas, Andrew Zloza, et al.
Frontiers in Immunology|December 27, 2016
IFN-λ: A New Inducer of Local Immunity against Cancer and InfectionsAhmed Lasfar, Andrew Zloza, Andrew de la Torre, et al.
Vaccines|December 28, 2021
Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer ImmunotherapyKajal H Gupta, Christina Nowicki, Eileena F Giurini, et al.
Blood|June 7, 2003
CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIVAndrew Zloza, Yvonne B Sullivan, Elizabeth Connick, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 26, 2014
High-dose IL-2 induces rapid albumin uptake by endothelial cells through Src-dependent caveolae-mediated endocytosisAndrew Zloza, Dae Won Kim, Joseph Broucek, et al.
Pageof 8